273 related articles for article (PubMed ID: 15941197)
21. FDA pilot programme in support of global harmonisation.
Donawa ME
Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
[TBL] [Abstract][Full Text] [Related]
22. New European guidance on borderline products.
Donawa ME;
Med Device Technol; 2009 Sep; 20(5):22, 24-5. PubMed ID: 19852178
[TBL] [Abstract][Full Text] [Related]
23. Beyond the US submisson process.
Donawa M
Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
[TBL] [Abstract][Full Text] [Related]
24. Ireland's competent authority initiatives.
Scully C
Stud Health Technol Inform; 1996; 28():101-11. PubMed ID: 10164084
[TBL] [Abstract][Full Text] [Related]
25. The US medical device bundling policy.
Donawa M
Med Device Technol; 2004 Nov; 15(9):25-7. PubMed ID: 16231784
[TBL] [Abstract][Full Text] [Related]
26. Proposed amendments to the medical devices Directives.
Donawa M
Med Device Technol; 2006; 17(1):22-5. PubMed ID: 16483107
[TBL] [Abstract][Full Text] [Related]
27. What is in the QSR/GMP?
Bartoo G;
IEEE Eng Med Biol Mag; 2004; 23(4):83-5. PubMed ID: 15508391
[No Abstract] [Full Text] [Related]
28. Conducting clinical studies in Italy.
Donawa M
Med Device Technol; 2005 Oct; 16(8):21-4. PubMed ID: 16355966
[TBL] [Abstract][Full Text] [Related]
29. Notifying the competent authorities.
Donawa ME
Med Device Technol; 1998 Nov; 9(9):12-6. PubMed ID: 10344879
[TBL] [Abstract][Full Text] [Related]
30. Effective risk management programmes.
Donawa M
Med Device Technol; 2004 May; 15(4):28-30. PubMed ID: 15303561
[TBL] [Abstract][Full Text] [Related]
31. The Netherlands' competent authority activities.
de Vries A
Stud Health Technol Inform; 1996; 28():106-11. PubMed ID: 10164085
[No Abstract] [Full Text] [Related]
32. France's competent authority initiatives.
Jullian E
Stud Health Technol Inform; 1996; 28():93-5. PubMed ID: 10164094
[No Abstract] [Full Text] [Related]
33. Medical device surveillance world-wide.
Badea C; Kolitsi Z; Pallikarakis N; Papapanagiotou A
Stud Health Technol Inform; 1996; 28():157-74. PubMed ID: 10184634
[No Abstract] [Full Text] [Related]
34. Addressing US and European device testing requirements.
Donawa M
Med Device Technol; 2008 Sep; 19(5):32, 34-7. PubMed ID: 18947148
[TBL] [Abstract][Full Text] [Related]
35. Activities in other European countries.
Ecker W; De Roo R; Frellsen M; Gomes AF; Gutowski R
Stud Health Technol Inform; 1996; 28():119-23. PubMed ID: 10164088
[TBL] [Abstract][Full Text] [Related]
36. Integrating risk management into the CAPA process.
Bills E; Tartal J
Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
[No Abstract] [Full Text] [Related]
37. Medical device reporting for user facilities.
Radiol Manage; 1992; 14(4):65-70. PubMed ID: 10123092
[TBL] [Abstract][Full Text] [Related]
38. Switzerland: one year's experience with new regulations and a new agency.
Voelksen R
Med Device Technol; 2003 Mar; 14(2):28-9. PubMed ID: 12698697
[TBL] [Abstract][Full Text] [Related]
39. [Focus Notified Bodies. New requirements for designation and monitoring].
Poos U; Edelhäuser R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Dec; 57(12):1362-7. PubMed ID: 25373553
[TBL] [Abstract][Full Text] [Related]
40. Finland's competent authority initiatives.
Pommelin P
Stud Health Technol Inform; 1996; 28():89-92. PubMed ID: 10164093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
